Literature DB >> 21671007

Role of Bim in apoptosis induced in H460 lung tumor cells by the spindle poison Combretastatin-A4.

G Mendez1, C Policarpi, C Cenciarelli, C Tanzarella, A Antoccia.   

Abstract

The BH3-only Bcl-2 subfamily member Bim is a well known apoptosis promoting protein. However, the mechanisms upstream of mitochondrion membrane permeability by which Bim is involved in apoptosis have been poorly investigated, particularly in response to agents capable of interfering with the cytoskeleton architecture and arresting cells in mitosis. Based on the observation that Bim is sequestered on the microtubule-array by interaction with the light chain of dynein, we have investigated upon depolymerisation, whether Bim could be involved in the commitment of apoptosis. With this purpose H460 Non Small Lung Cancer Cells (NSLC) were treated with the microtubule damaging agent combretastatin-A4 (CA-4) (7.5 nM; 8-48 h), and various parameters were investigated. Upon treatment, cells arrested in mitosis and died through a caspase-3-dependent mitotic catastrophe. Transient knock down of Bim drastically reduced apoptosis, indicating that this protein was involved in cell death as induced by microtubules disorganisation. In response to increasing conditions of microtubules depolymerisation, we found that the protein level of Bim was strongly upregulated in a time-dependent manner at transcriptional level. Furthermore, Bim was released from microtubule-associated components. Bim was translocated to mitochondria, even in a condition of protein synthesis inhibition, where it showed a markedly increased interaction with Bcl-2. In turn, the fraction of Bax bound to Bcl-2 decreases in response to treatment, thereby indicating that Bim possibly promotes Bax release from the pro-survival protein Bcl-2. Overall, we demonstrated that Bim is required for the CA-4-induced cell death in the H460 lung cancer cell line via activation of the mitochondrial signalling pathway. Defining the contribution of Bim to the mechanism of apoptosis may offer some different clues in view of developing new strategies for chemotherapy with CA-4, underlining the relevance of the cytoskeleton integrity in the apoptotic response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671007     DOI: 10.1007/s10495-011-0619-8

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agents.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Marcella Bassetto; Andrea Brancale; Ernest Hamel; Ignazio Castagliuolo; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

2.  Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: 4β-S-aromatic heterocyclic podophyllum derivatives display antitumor activity.

Authors:  Jian-Long Li; Wei Zhao; Chen Zhou; Ya-Xuan Zhang; Hong-Mei Li; Ya-Ling Tang; Xin-Hua Liang; Tao Chen; Ya-Jie Tang
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

3.  Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest.

Authors:  Daniel Tarade; Dennis Ma; Christopher Pignanelli; Fadi Mansour; Daniel Simard; Sean van den Berg; James Gauld; James McNulty; Siyaram Pandey
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

4.  Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.

Authors:  Tarek S Ibrahim; Mohamed M Hawwas; Azizah M Malebari; Ehab S Taher; Abdelsattar M Omar; Thikryat Neamatallah; Zakaria K Abdel-Samii; Martin K Safo; Yaseen A M M Elshaier
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

5.  Boolean network-based model of the Bcl-2 family mediated MOMP regulation.

Authors:  Tomas Tokar; Zdenko Turcan; Jozef Ulicny
Journal:  Theor Biol Med Model       Date:  2013-06-14       Impact factor: 2.432

6.  Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Filippo Prencipe; Paola Oliva; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Luisa Carlota Lopez-Cara; Salvatore Ferla; Andrea Brancale; Ernest Hamel; Roberto Ronca; Roberta Bortolozzi; Elena Mariotto; Giuseppe Basso; Giampietro Viola
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.